CRISPR Gene Editing can Treat Deadly Lung Diseases Before Birth
Chennai, April 20 -- Highlights:
* Surfactant is a lipoprotein mixture which is important for normal lung functioning
* Mutations in the surfactant genes lead to fatal lung diseases like surfactant //protein deficiency, cystic fibrosis and alpha-1 antitrypsin
* Such fatal diseases can lead to immediate death after birth due to respiratory failure
* Using CRISPR gene editing in-utero, scientists have edited out the harmful mutations
* This proof-of-concept is a new beginning to deal with harmful lung diseases in fetuses before birth
CRISPR gene edits out a harmful mutation in surfactant genes which cause monogenic lung diseases. This gene editing tool can now help treat deadly lung diseases in fetuses before birth, reveals a new stud...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.